Recruiting Osteogenesis Imperfecta Studies in Buenos Aires
A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)
Researchers are looking for new ways to treat certain types of advanced gastrointestinal (GI) cancers. The study medicine raludotatug deruxtecan (also called MK-5909, R-DXd, or DS-6000a) is a type of ...
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
A Phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of paltusotine treatment vs placebo as well as the long-term safety of paltusotine in adults with ca...
About Osteogenesis Imperfecta Clinical Trials in Buenos Aires
Osteogenesis imperfecta is a group of genetic disorders mainly affecting the bones, causing them to break easily, often from little or no apparent cause. It is caused by defects in collagen production. Treatment includes bisphosphonates, physical therapy, and surgical rodding.
There are currently 2 osteogenesis imperfecta clinical trials recruiting participants in Buenos Aires, ARGENTINA. These studies are seeking a combined 301 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Crinetics Pharmaceuticals Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Osteogenesis Imperfecta Clinical Trials in Buenos Aires — FAQ
Are there osteogenesis imperfecta clinical trials in Buenos Aires?
Yes, there are 2 osteogenesis imperfecta clinical trials currently recruiting in Buenos Aires, ARGENTINA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Buenos Aires?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Buenos Aires research site will contact you about next steps.
Are clinical trials in Buenos Aires free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Buenos Aires studies also compensate for your time and travel.
What osteogenesis imperfecta treatments are being tested?
The 2 active trials in Buenos Aires are testing new therapies including novel drugs, biologics, and treatment approaches for osteogenesis imperfecta.
Data updated March 2, 2026 from ClinicalTrials.gov